• Our Location
  • Damson Pkwy, Solihull B91 2PP. 01217045528
  • working hours
  • Mon - Fri : 9:00 Am - 7:00 Pm

Our Publications

1.Elevated D-dimers are also a marker of underlying malignancy and increased mortality in the absence of venous thromboembolism.

Knowlson L, Bacchu S, Paneesha S, McManus A, Randall K, Rose P.
J Clin Pathol. 2010 Sep;63(9):818-22. Epub 2010 Jul 29.
PMID:20671046
[PubMed - indexed for MEDLINE] 


2. Successful pregnancy in a case of congenital thrombotic thrombocytopenic purpura. Meti S, Paneesha S, Patni S.

J Obstet Gynaecol. 2010;30(5):519-21. No abstract available. 
PMID:20604662
[PubMed - indexed for MEDLINE] 


3. Risk factors for cancer-associated venous thromboembolism in outpatient deep venous thrombosis clinics.

Rose P, McManus A, Arya R, Scriven N, Farren T, Nokes T, Bacon S, Cooper D, O'Shaughnessy D, Paneesha S.

Br J Haematol. 2010 Sep;150(5):640-1. Epub 2010 Jun 17. No abstract available. 
PMID:20560972
[PubMed - indexed for MEDLINE] 

 

4. Allogeneic transplant outcomes are not affected by body mass index (BMI) in patients with haematological malignancies.

Nikolousis E, Nagra S, Paneesha S, Delgado J, Holder K, Bratby L, Chaganti S, Lovell R, Milligan D.

Ann Hematol. 2010 Nov;89(11):1141-5. Epub 2010 Jun 11.
PMID:20544351

5. Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at outpatient DVT clinics. Paneesha S, McManus A, Arya R, Scriven N, Farren T, Nokes T, Bacon S, Nieland A, Cooper D, Smith H, O'Shaughnessy D, Rose P. Thromb Haemost. 2009 Dec 18. [Epub ahead of print]

6. More on thromboprophylaxis: Quantifying risk for venous thromboembolism. Arya R, Paneesha S, McManus A, Parsons N, Scriven N, Farren T, Nokes T, Smith H, O'Shaughnessy D, Rose P. Thromb Haemost. 2009 Apr;101(4):791-4.

7. "Viral" myocarditis in a patient following allogenic stem cell transplant: Diagnostic dilemma and management considerations. Bhattacharya S, Paneesha S, Chaganti S, Lovell R, Slocombe G, Milligan D, Osman H. J Clin Virol. 2009.

8. Research paper: High D-dimer levels at presentation in patients with venous thromboembolism is a marker of adverse clinical outcomes. S. Paneesha, E. Cheyne, K. French, S. Bacchu, A. Borg and P. Rose. British Journal of Haematology, 2006 135:1, 85.

9. Review: Stem cell transplantation for chronic lymphocytic leukaemia. S. Paneesha & D.W. Milligan. British Journal of Haematology, 2005 128:2, 145-152.

10.The P2X7 receptor gene polymorphism 1513 A-C has no effect on clinical prognostic markers and survival in multiple myeloma. S Paneesha, J Starczynski, C Pepper, L Hooper, C Fegan & G Pratt. Leukemia & Lymphoma, 2006. 47:2, 281-284.

11. Review: Management of thrombogenecity of Thalidomide in myeloma. M Kumar, S Paneesha & A Borg. Thrombus 2006, 9(4).

12.Burkitt’s lymphoma: Single-centre experience with modified BFM protocol: E. Harris, S. Paneesha, N. Jackson, L. Jones & P. Mahendra. Journal of Clinical & Laboratory Haematology, 2002, 24, 111-114.

13.Repair of DNA interstrand cross-links as a mechanism of clinical resistance to Melphalan in Multiple Myeloma. V J Spanswick, C Craddock, M Sekhar, P Mahendra, S Paneesha, R G Hughes, D Hochhauser & J A Hartley. Blood, 2002. 100, 224-229.

14.Peripheral blood stem cell transplantation for POEMS syndrome. KS Peggs, S Paneesha, PD Kottaridis, RK Chakraverty, G Tobias, M Reilly, P Mahendra & K Yong. Bone Marrow Transplantation, 2002. 30, 401-405.

15.Effect of Salvage Therapy with High-Dose Cytarabine and Amsacrine Prior to Autologous or Allogenic Transplantation for High-Risk Leukaemia. S Tauro, S Paneesha, I Nitu-Whalley, N Duncan, JO Craig, RE Marcus, CF Craddock and P Mahendra. Bone Marrow Transplant. 2003 Aug; 32(3):273-8.

16.The SDF-1 G?A polymorphism at position 801 plays no role in multiple myeloma but trends towards an inferior cause specific survival in chronic lymphocytic leukaemia Pemberton NC, Paneesha S, Hiller L, Starczynski J, Hooper L, Pepper C, Pratt G, Fegan C. Leuk Lymphoma. 2006;47(7):1239-44.

17. High D-dimer level at presentation in patients with venous thrombosis is a marker for malignancy. S Paneesha, E Cheyne, K French, J Delgado, A Borg, P Rose. E-letter, haematologica 2005; 90: (ELT) 08.

18.Case report: Successful treatment of a patient with chronic lymphocytic leukaemia (CLL) presenting with bony metastases with aggressive antibody and chemotherapy. Narayan H, Bandyopadhyay D, Schmidt K, Chachlani N, Hughes M, Paneesha S, Rose P, Borg A. Clinical and Laboratory Haematology, 2005; 27(6), 405-408.

19. Image in Blood Med. Pamidronate induced osteonecrosis of the jaw in a myeloma patient.
S Paneesha, N Barnard, U Udeshi, S Shafeek. https://www.bloodmed.com/education/case1.asp?id=194.

20.Image in Blood Med. Variant acute promyelocytic leukaemia presenting with massive intracerebral haemorrhage. S Paneesha, S Shafeek, C Phillips and R Stockley
https://www.bloodmed.com/education/case1.asp?id=195.

21.An unusual cause of red cell fragmentation and thrombocytopenia. 
D Bandyopadhyay, S Paneesha, N Chachlani, M Hughes, H Narayan, A Borg & P Rose. http://www.bloodmed.com/education/case1.asp?id=175.

22.Image in BloodMed: All that Glitters is not gold. S Paneesha, R Pol, N Chachlani, M Hughes, K Chen, P Rose & A Borg. http://www.bloodmed.com/education/case1.asp?id=206.

23.Review: Chronic lymphocytic leukaemia. S Paneesha & DW Milligan. Geriatric Medicine, 2006; 36(6), 23-28.

24.Case report: Internal jugular vein thrombosis: a late complication of ovarian stimulation in the absence of thrombophilia. Jhansi Muddana, S Paneesha & P Rose. Thrombus 2006, 10(3).

25.Calciphylaxis: rarely seen and poorly understood. G Purohit, J MR Goulding, R Charles-Holmes, P Rose & S Paneesha. Thrombus 2008, 11(4).

26.Obesity and venous thromboembolism. V Singh, S Paneesha & P Rose. Thrombus 2007, 11(3).

27. Image in BloodMed: Unusual co-occurrence of chronic lymphocytic leukaemia and systemic mastocytosis. 
M Nikolousis, D Milligan, Z Rudzki, S Paneesha & G Pratt. http://www.bloodmed.com/education/case1.asp?id=269.